Skip to main content
. 2024 Oct 12;16(10):e71341. doi: 10.7759/cureus.71341

Table 3. Relationship between plasma 5-FU concentration and adverse events.

Concentrations are expressed as median (interquartile range). The differences between groups were estimated using the Mann-Whitney test for continuous variables. 

Adverse events 5-FU blood concentration (ng/ml) p-value
Diarrhea (-) 94 [64.5–149.5]  
(+) 129 [69–192] 0.363
Stomatitis (-) 95.5 [32–307]  
(+) 137 [38–187.5] 0.361
Nausea (-) 91.0 [67–149.7]  
(+) 131 [60.5–187] 0.604
Loss of appetite (-) 123.5 [60.7–159.5]  
(+) 95.5 [68.5–187.5] 0.884
Fatigue (-) 132.5[60.7–193.5]  
(+) 95.5 [60.7–136] 0.384
Hand–foot syndrome (-) 119.0 [68.7–139.7]  
(+) 142.5[64.5–229.5] 0.299
Constipation (-) 110.5 [67.4–169.5]  
(+) 104 [64.5–172.5] 0.99
Leukopenia (-) 111.5 [66.5–148.2]  
(+) 106 [67–20.5.] 0.446
Neutropenia (-) 95.5 [65.7–143]  
(+) 131.5 [73–205.5] 0.194
Anemia (-) 127.0 [69–186]  
(+) 94 [41.5–148.5] 0.157
Thrombocytopenia (-) 95.5 [63.3–151.7]  
(+) 126.5 [70.5–190.5] 0.392